?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
News
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
December 12, 2024
Katie Quinn
Biosimilars Forum Welcomes Henlius as Newest Member
News
August 15, 2024
Katie Quinn
Biosimilars Forum Calls on CMS to Support Lower-Cost Biosimilars and Increase Access for Patients
News
July 24, 2024
signalgroup
The Biosimilars Forum Supports House Committee on Oversight and Accountability Probe Into the PBM Monopoly
News
July 9, 2024
signalgroup
Biosimilars Forum Calls for Reform of the PBM Monopoly
News
March 20, 2024
signalgroup
Biosimilars Forum Announces Support for Increasing Access to Biosimilars Act
News
March 14, 2024
signalgroup
Biosimilars Forum Urges Congress to Support Free Market Competition and Lower Prescription Drug Prices for Patients by Reforming Pharmacy Benefit Managers
News
January 24, 2024
signalgroup
Biosimilars Forum Welcomes Teva as Newest Member
News
January 10, 2024
signalgroup
Biosimilars Forum Welcomes Biocon Biologics as Newest Member
News
November 30, 2023
signalgroup
Julian Malasi Member Spotlight
News
November 16, 2023
signalgroup
Affordable prescription drugs exist — why can’t more patients access them?
01
02
03
Next page